Compare Live Nation Entertainment, Inc. (LYV) vs Medtronic PLC (MDT) Price & Performance

Live Nation Entertainment (LYV) trades at $170.84, down 0.55% on the day, with technical indicators showing a bullish trend despite recent price weakness. The company reported Q2 2026 earnings beat with 9% revenue growth and record deferred revenue of $6.4 billion, though profitability remains challenged with a net margin of just 0.51%. Analyst sentiment remains strongly positive with 87% buy ratings and a $208.18 consensus price target, representing 22% upside potential from current levels.

The outlook remains favorable given strong consumer demand for live events and the company's dominant market position, though investors face risks from elevated valuation multiples (P/E of 117.5), regulatory scrutiny, and execution challenges in managing cost pressures. The stock's performance will depend on continued demand strength and successful navigation of legal and operational headwinds through 2026.

Medtronic (MDT) trades at $85.51, down 1.81% on the day, showing bearish technical signals despite strong fundamental performance. The company has beaten earnings estimates for three consecutive quarters with Q3 2026 results pending, while maintaining robust profitability margins of 65% gross and 14% net. Recent news highlights the company's 49-year dividend growth streak and new product approvals, though technical indicators show selling pressure with the stock trading near support at $85.

MDT presents a compelling value opportunity with a 3.2% dividend yield and 14% upside to the $97.80 consensus target, though near-term technical weakness and increasing debt levels warrant caution. The company's consistent earnings beats and medical device market leadership support long-term growth, while regulatory approvals for new systems provide catalysts.